Targeted high-LET therapy of bone metastases
ØS Bruland, D Jostein, DR Olsen… - … Tumor Therapy: Biological …, 2008 - Springer
Bone metastases cause pain, and may result pathological fractures, spinal cord
compression and bone marrow insufficiency. External beam radiation relieves pain, but this …
compression and bone marrow insufficiency. External beam radiation relieves pain, but this …
Körperliche Bewegung in der onkologischen Palliativmedizin
FT Baumann, E Jäger, W Bloch, E Jäger - Sport und körperliche Aktivität in …, 2012 - Springer
Die palliative Therapie in der Onkologie ist ein interdisziplinäres Behandlungskonzept mit
dem Ziel, die Lebensqualität lebensbedrohlich erkrankter Patienten, die keine wesentlichen …
dem Ziel, die Lebensqualität lebensbedrohlich erkrankter Patienten, die keine wesentlichen …
Samarium-153–Lexidronam Therapy for Metastatic Bone Pain
H Ribera - Journal of Pain & Palliative Care Pharmacotherapy, 2013 - Taylor & Francis
Multidisciplinary management may offer alternative therapeutic strategies in patients. Bone-
seeking radiopharmaceuticals offered alongside traditional approaches to analgesia may be …
seeking radiopharmaceuticals offered alongside traditional approaches to analgesia may be …
Pain control with palliative radiotherapy in patients with bone metastases
M Popovic, R Chow, N Lao, G Bedard, E Chow - Bone Cancer, 2015 - Elsevier
Bone metastases remain the most common cause of cancer-related pain. Multiple treatment
approaches are currently available for alleviating pain from bone metastases. Among them …
approaches are currently available for alleviating pain from bone metastases. Among them …
Traitement antalgique des métastases osseuses douloureuses par radiothérapie interne vectorisée
L Tessonnier, C Ciais, L Valerio, X Fontana, P Carrier… - Médecine nucléaire, 2007 - Elsevier
Résumé L'objectif de cette étude rétrospective est l'évaluation de l'efficacité et de la toxicité
du Quadramet® et du Metastron®, administrés chez 76 patients ayant des métastases …
du Quadramet® et du Metastron®, administrés chez 76 patients ayant des métastases …
Radiotherapy of skeletal metastases
O Bruland, A Hird, E Chow - … on the Metabolic Bone Diseases and …, 2009 - books.google.com
Bone is the most common site of symptomatic cancer metastasis. Two thirds to three
quarters of patients with advanced disease from breast and prostate carcinomas have …
quarters of patients with advanced disease from breast and prostate carcinomas have …
[PDF][PDF] Prostate Cancer: Targeting for Precision Radiotherapy
DA LIMJOON - 2021 - scholar.archive.org
2. Davis ID, Lee ST, Shanker L, Clouston D, Bolton DM, Angus D, Webb D, Lawrentschuk N,
Woon DT, Esler S, Lim Joon D, Chang J, O'Sullivan R, Pathmaraj K, Tochon-Danguy H …
Woon DT, Esler S, Lim Joon D, Chang J, O'Sullivan R, Pathmaraj K, Tochon-Danguy H …
Korrelationsanalyse von PSMA-Expression und Mineralisation in Knochenmetastasen von Prostatakarzinomen in vivo gemessen mit Ga-68-HBED-CC-PSMA-PET/CT
B Marchner - 2021 - epub.uni-regensburg.de
PSMA (Prostata-spezifisches Membranantigen) ist ein Transmembran-Glykoprotein mit
einer hohen Expression auf Prostatakarzinomzellen. Für diese Zielstruktur wurde das …
einer hohen Expression auf Prostatakarzinomzellen. Für diese Zielstruktur wurde das …
Synthesis design and nuclear medicine applications for radiometal, beta and gamma emission, chelated complexes
AN Dame - 2017 - mospace.umsystem.edu
Nuclear medicine covers a wide variety of radionuclides to meet demands of disease. In the
current study, first we have looked at the application of mono-amine mono-amide ligands for …
current study, first we have looked at the application of mono-amine mono-amide ligands for …